Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients' lives. Through our Genome5000 program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexi